Why the study?
Does transaortic valvular implantation improve symptoms in an elderly patient with systemic sclerosis and severe aortic stenosis?
Case Report (n=1)
Does transaortic valvular implantation improve symptoms in an elderly patient with systemic sclerosis and severe aortic stenosis?
Transaortic valvular implantation is a viable and practical therapeutic option for high-risk, inoperable patients with severe aortic stenosis and systemic sclerosis.
Systemic sclerosis is a connective tissue disorder that frequently involves the heart. All cardiac structures can be involved but aortic valve involvement is rare. We report a case of an 83-year-old man with a history of systemic sclerosis presenting with shortness of breath. A transthoracic echocardiogram revealed severe aortic stenosis that could not be explained by other causes. These patients often pose challenges in management as they are not surgical candidates. Transaortic valvular implantation is a viable option for these patients.
No takes yet. Share an insight, caveat, or question.
Kagalwalla et al. (2017) conducted a case report in Systemic sclerosis and severe aortic stenosis (n=1). Transaortic valvular implantation (TAVI) was evaluated on Symptom improvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: